Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Technische Universität München

Munchen, DE

Technische Universität München Patent applications
Patent application numberTitlePublished
20130129622CYCLOPENTAPEPTIDE DERIVATIVES AND USES THEREOF - The present invention, among others, relates to a compound having a structure according to formula (I) or a pharmaceutically acceptable salt thereof, wherein Xaa05-23-2013
20120201672SHAFT POWER PLANT - A shaft power plant (08-09-2012
20110104695METHODS OF PREDICTING THERAPEUTIC EFFICACY OF CANCER THERAPY - The present invention relates to novel methods and kits for predicting, prognosing, and/or monitoring therapeutic efficacy of cancer therapy on a subject having malignant tumor or cell proliferative disorder.05-05-2011
20090038419Sample System For Fluid Samples - The present invention relates to a sampling system for fluid samples having sample receiving vessel for receiving the sample, which is sealed by a septum and holder for the sample receiving vessel for receiving and holding the sample receiving vessel and also a sample probe for dipping into a fluid volume and for taking a fluid sample from the fluid volume, the sample probe being configured as a hollow volume which, at one end, has a first opening for introducing the holder and the sample receiving vessel and, at another end, is sealed by a first valve which is provided with a hollow needle which projects into the interior of the sample probe said valve being able to be opened by contact with the holder and/or with the sample receiving vessel and then connecting the exterior of the sample probe to the inner volume of the hollow needle.02-12-2009
20080305038Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells - The present invention refers to novel conjugate molecules and their use or the transport of nano- and macromolecular structures into cells and/or the nucleus. More particularly, the present invention refers to conjugate molecules containing a carrier, preferably thiopyridyl moieties, and a cargo moiety. Thereby, the thiopyridyl moiety is bound to the cargo moiety to act as a carrier, particularly for efficient intracellular and/or intranuclear delivery of drugs, nano-or macromolecular structures, etc. The novel conjugate molecules are provided for the manufacture of a medicament for gene therapy, apoptosis, or for the treatment of diseases such as cancer, autoimmune diseases or infectious diseases.12-11-2008

Patent applications by Technische Universität München